# SAM #NSF-Topic4-FY26-XLabsSequence-to-Function

NSF X-Labs bioengineering R&D team awards

**Buyer:** TIP - CORE PROGRAMS
**Posted:** October 14, 2026
**Respond By:** February 08, 2027
**Identifier:** NSF-Topic4-FY26-XLabsSequence-to-Function
**NAICS:** 541714, 541715

The U.S. National Science Foundation is seeking bioengineering teams to develop transformative platform technologies through its NSF X-Labs initiative.
- Government buyer: U.S. National Science Foundation (NSF), Directorate for Technology, Innovation and Partnerships (TIP).
- **OEMs and vendors:** No product manufacturers, OEMs, or commercial vendors are identified.
- Requested work: Full-time R&D teams developing novel platform technologies with the potential to create high-impact scientific or technological breakthroughs, including in bioengineering.
- Award phases:
  - Phase 0: 9–12 months, up to $1.5 million, for concept development, milestone refinement, and preparation for a full team.
  - Phase 1: 24–36 months, up to $50 million per year, to execute the team’s mission, scale operations, and recruit full-time team members.
  - Phase 2 renewal may be available based on performance; advancement between phases is milestone-based.
- Key requirements: Teams should demonstrate operational autonomy and independence. Senior and key personnel are expected to be dedicated full-time by Phase 1.

### Description

<p>The National Science Foundation (NSF) Directorate for Technology, Innovation and Partnerships&nbsp;(TIP) announces its intent to solicit Written Proposals for NSF X-Labs teams in the technical&nbsp;domain of bioengineering. This NSF X-Labs announcement is issued under the Other&nbsp;Transactions Agreement Solutions Offering (OTASO), NSF-OTASO-FY26-XLabsInitiative.</p>

[View original listing](https://sam.gov/opp/4da70f039bbc4e2fbddce36bc55ab394/view)